Resverlogix's Lead Drug Featured in Key Scientific Publication
CALGARY, Canada, July 18 /PRNewswire/ --
- RVX-208 is the Only Apo-Al/HDL Drug to be Highlighted
Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce that Resverlogix'…